Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme
Author
Challapalli, AWatkins, S
Cogill, G
Stewart, G
Ellis, S
Sykes, A
Nobes, J
Yip, K
Barthakur, U
Board, R
Gadve, A
O'Toole, L
Kent, C
Mackenzie, J
Papa, S
Fusi, A
Fife, K
Publication date
2022-03-17
Metadata
Show full item recordAbstract
No abstract available.Citation
Challapalli A, Watkins S, Cogill G, Stewart G, Ellis S, Sykes A, Nobes J, Yip K, Barthakur U, Board R, Gadve A, O'Toole L, Kent C, Mackenzie J, Papa S, Fusi A, Fife K. Cemiplimab in advanced cutaneous squamous cell carcinoma: the UK experience from the Named Patient Scheme. J Eur Acad Dermatol Venereol. 2022 Jul;36(7):e590-e592. doi: 10.1111/jdv.18082. Epub 2022 Mar 24.Type
CorrespondenceAdditional Links
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1468-3083PMID
35298050Publisher
Wileyae974a485f413a2113503eed53cd6c53
10.1111/jdv.18082